Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics
YI Miller, S Tsimikas - Current opinion in lipidology, 2013 - journals.lww.com
YI Miller, S Tsimikas
Current opinion in lipidology, 2013•journals.lww.comUsing the accelerating knowledge base and improved understanding of the interplay of
oxidation, inflammation and innate and adaptive immunity in atherogenesis, emerging
clinical applications of oxidation-specific antibodies may identify, monitor and treat CVD in
humans.
oxidation, inflammation and innate and adaptive immunity in atherogenesis, emerging
clinical applications of oxidation-specific antibodies may identify, monitor and treat CVD in
humans.
Summary
Using the accelerating knowledge base and improved understanding of the interplay of oxidation, inflammation and innate and adaptive immunity in atherogenesis, emerging clinical applications of oxidation-specific antibodies may identify, monitor and treat CVD in humans.
Lippincott Williams & Wilkins